Multiple sclerosis (MS) is a devastating degenerative neurological disease that has among its sequelae significant urological pathology. Sexual and bladder dysfunction are the most common. Both of these sequelae can have a major effect on a patient's ability to function emotionally and socially. We shall review the pathogenesis of bladder and sexual dysfunction in the MS patient and discuss available diagnostic and treatment modalities.
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Multiple sclerosis (MS) is the third most common chronic debilitating disease in the United States, behind arthritis and trauma, and affects 130,000 patients in the United States and 50,000 patients in the United Kingdom alone (1, 2) . This is a progressively degenerative neurological disease of young adults that has an onset generally between the ages of 20 and 40 years (3) . MS has an incidence in England of 1 in 2,000 and 1 in 800 in Hebrides, Scotland (2) . The overall incidence of MS in the United States is approximately 3.5 new cases per 100,000 persons per year. The onset of this disease occurs during the most productive years of a young adult's life, when impairment of sexuality and fertility can have devastating effects.
MS is an inflammatory process of the central nervous system (CNS) marked by infiltrating lymphocytes and macrophages that attack the myelin sheaths. The lateral columns of the spinal cord contain the pathways responsible for potency and bladder function and are the most frequently affected sites in MS (4) . The major pathologic feature, focal demyeliniza-tion, results in plaque formation at multiple levels in the CNS, which is further characterized by loss of oligodendrocytes and proliferation of fibrous astrocytes (5) . The resultant loss of the insulating properties of myelin sheaths causes abnormal saltatory nerve conduction, which leads to partial, intermittent, or complete blocks in neuronal conduction velocity.
Periods of exacerbation and remission are a hallmark of this disease.
Epidemiology
Sexual dysfunction has been recognized as a sideeffect of MS for almost 25 years. Numerous studies have been conducted in the past two decades that have shown that the percentage of males and females with MS and sexual dysfunction is significant. Impotence was found to be the presenting symptom in 7% of the males in a study by Ivers and Goldstein (6) . Although sexual problems have been recognized for quite some time, there have been only two published studies on the physiological basis of sexual dysfunction in the MS patient. Ivers and Goldstein (6) reported a 26% incidence of erectile dysfunction in 54 patients with MS at the Mayo Clinic. Kinsey et al. estimated that impotence affected 18% of the American population at the age of 60 (7) . The first study to specifically look at erectile dysfunction and MS was conducted by Vas and in- volved 37 males with MS (8) . He found that 43% of the subjects were either totally or partially impotent. He also found that MS patients who were experiencing erectile impairment had a higher incidence of bladder and bowel dysfunction. Lilius et al. conducted a study using a questionnaire in which 302 patients suffering from MS anonymously answered questions concerning sexuality and other issues dealing with their disease (9) . These patients were selected from the MS association of Helsinki, Finland. They found that the sexual life in 91% of the males and in 72% of the females had changed. These patients were, as a rule, in relatively poor condition, with one-fifth being permanent invalids and 60% with grave disability (e.g., ambulating only with the aid of a walker or crutches). It was felt that the most significant causes of sexual dysfunction in MS are lesions of the lateral horns of the lumbar cord and low levels of testosterone (8) . Lilius et al. found a 94% occurrence of pyramidal tract symptoms and a 78% occurrence of bladder disturbance. These percentages were found to equal the 91% frequency of occurrence of sexual dysfunction in patients with MS. The most significant factor in the development of impotence was felt to be not the duration of MS but the location of the plaques in the CNS. They found that sexual functioning had ceased or had become unsatisfying in 64% of the males whom they had studied. The most common problems with the males were found to be loss of erection (48%), weak erection (9%), generalized weakness (9%), spasticity (8%), frigidity of the wife (6%), and periodic loss of erection (5%). Inwomen, loss of orgasm was reported as the main cause of their sexual dysfunction 33% of the time and loss of libido 27% of the time.
MS can affect sexual functioning in numerous ways. It can be manifested as loss of ejaculation, decreased sensibility and paresthesia of the genitalia, or absence of vaginal lubrication. There are many psychological stresses associated with the burden of a chronic, debilitating disorder such as MS that can greatly affect one's ability to maintain normal intimacy and sexuality. Thus, it may be difficult to differentiate between organic and psychologically induced sexual dysfunction. Therefore, one must be careful not to create the syllogism: he has MS, he complaills of impotence, therefore the MS is causillg the impotence. In (10) . They found that 71% of the males and 74% of the females were experiencing some degree of sexual dysfunction, with 48% of the men and 44% of the women reporting significant abnormalities. They also reported a significant correla-tion (p < 0.01) between the presence of sexual dysfunction and bladder-bowel dysfunction. This group also found, as in other studies, that the incidence of erectile dysfunction was not related to the severity of sequelae, age of the patient, or duration of MS. What is strikingly consistent in all of these studies is that there is a high incidence of sexual dysfunction in patients stricken with MS and that there is a strong correlation between sexual dysfunction and bladderbowel continence problems.
Brief Review of Erectile .
Neurophysiology
The maintenance of erectile function requires the interplay of several factors. Stimulation of an erection may result from cortical stimuli as the result of olfactory, tactile, auditory, and mental sensations. The major factors involved in generating the erectile response are (a) a normal hypothalamic-pituitary axis, (b) a patent penile arterial system, (c) a competent veno-occlusive mechanism, and (d) an intact connection with the CNS. Psychological factors can influence an individual's sexual desire (i.e., libido), the ability to become aroused, ejaculatory function, the quality of the sexual experience, and the memories that will be associated with sexual encounters (11) . Two neurological centers responsible for tumescence are in the sacral spinal cord (S2-S4) and the thoracolumbar spinal cord (T12-L1).
Cortically stimulated erections are felt to be mediated by thoracolumbar outflow and the hypogastric plexus (11) . Local stimulation of the penis can result in a reflexogenic erection that is mediated by afferent nerve fibers of the penis via the pudendal nerve and efferent nerve fibers via the parasympathetics of S2 and S4, which are components of the nervi erigentes. Neurologic stimulation results in the local release of neurotransmitters and other vasoactive agents that induce vascular and corporal smooth muscle relaxation. The end result is vasodilation and increased blood flow into both corporal bodies. As the spongy corporal erectile tissues are filled to adequate rigidity, there is passive occlusion of the draining venules and emissary veins against the tunica albuginea. Failure of any of these mechanisms can result in erectile dysfunction.
Brief Review of Bladder

Neurophysiology
The maintenance of normal bladder function is primarily a neurological event. The normal bladder has viscoelastic properties that allow it to hold increasing volumes of urine without a corresponding rise in intravesical pressure (up to a point!).
The bladder and other components of the lower urinary tract are innervated by parasympathetic, sympathetic, and somatic nerves. The anterior segment of the pelvic plexus is responsible for innervating the bladderand the sphincteric region of the urethra. The preganglionic parasympathetic components of the pelvic plexus originate in the intermediolateral gray columns of the sacral spinal cord (S3-S4) and are called the pelvic splanchnic nerves or nervi erigentes. There are also ganglia located on the surface of the bladder and in the bladder wall; the ganglia supply postganglionic neurons to the detrusor muscle bundles (12) . These postganglionic parasympathetic nerves are cholinergic, and their action is mediated by the neurotransmitter acetylcholine.
The sympathetic component of the pelvic plexus originates in the intermediolateral gray columns of the thoracolumbar spinal cord (-Tl O-L2). The action of the postganglionic sympathetic nerves is mediated by the neurotransmitter noradrenaline; therefore, the nerves are called adrenergic nerves. Sympathetic nerves supply the trigone of the bladder and the bladder neck (specifically, the preprostatic sphincter region in males).
The intrinsic rhabdosphincter of the bladder is supplied by somatic nerves that are largely derivatives of the pudendal nerve (S2-S4). Evidence published by Vernet (13) and Gosling (14) suggested that these nerves follow the same anatomical course as the hypogastric nerves. The cell bodies of the somatic nerves appear to be concentrated on the anterior horns of S2-S4. These are considered atypical a-motoneurons because of their unusual site of origin in the sacral spinal cord. The innervation of the upper pelvic musculature is derived from typical a-motoneurons arising directly from the anterior primary rami of S3, S4, and sometimes S5. The pelvic sling muscles are in the upper surface of the pelvic floor. The musculature of the perineum, which are the pelvic sling, are primarily supplied by branches of the pudendal nerve and the perineal nerves (S2-S4) .
It should be evident that there is significant overlap in the innervation of the bladder and genitals. Rectal sphincter tone and fecal continence are also affected because the rectopubic sling is an integral component of the pelvic and perineal musculature and is largely responsible for the maintenance of urinary and fecal continence. Lesions on the lower spinal cord can cause significant sexual, bowel, and urinary dysfunction.
Erectile Dysfunction and MS
Clinical neurologists have been aware of the high incidence of impotence associated with long-standing MS. Impotence, as defined by Masters and Johnson, is a disturbance of sexual function in the male that precludes satisfactory coitus (15) . This disturbance ranged from a total loss of &dquo;erective prowess&dquo; (total impotence) to an inability to attain or maintain a full erection (partial impotence) (8) .
The first study of erectile dysfunction in MS was conducted by Vas in 1969 . He studied 37 males with MS, all of whom were not significantly disabled, having a score of no greater than 5 on the Kurtzke Disability Status Scale (16) . All of the patients were capable of being ambulatory for at least 12 h in the course of the day. Sixteen (43.2%) of his study population reported some degree of impotence. Neurological functioning was assessed based on pyramidal, brainstem, sensory, and bladder-bowel functioning (according to the Kurtzke Scale). It was observed that the impotent males complained more frequently of urinary frequency or retention. ' The autonomic nervous system was also evaluated in this study, with emphasis placed on the clinical presence of orthostatic hypotension and the state of sudomotor function (the ability to perspire). Vas did find a relationship between erectile dysfunction and anhydrosis. Totally impotent men were found not to perspire below the level of the iliac crest, partially impotent men did not perspire on the lower limbs, and nonimpotent men perspired over their entire bodies. It was Vas' contention that disturbances of sweating and erectile function, when coexistent, imply the presence of abnormalities of the lateral horns of the dorsolumbar cord or their connections.
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Vas also tested lumbosacral reflexes (scrotal, bulbocavernosus, and rectal) and found these to be absent in the totally impotent men and some of the partially impotent men. Urinary gonadotrophin levels were measured and were found to be elevated in approximately 66% of the totally impotent males and 37% of the partially impotent males. The significance of the abnormal sympathetic and parasympathetic (lumbosacral) reflexes, elevated urinary gonadotrophins, and disturbances of autonomic function may be further evidence of the presence of lesions in the lumbar sympathetic and sacral parasympathetic areas.
Probably the most important finding by Vas was the oscillating nature of the sexual dysfunction in 11% of the subjects. He found that, over the course of a year, just as many patients experienced improvement in sexual performance as did those who experienced deterioration. This is very useful information for sexual counseling of these patients. In (17) . No evidence of arteriogenic, venogenic, or hormonal abnormalities that might contribute to impotence in this group was found. However, 26 of the 29 patients had abnormal pudendal evoked potentials (PEP), indicating damage to the penile cortical pathways. Local pathways via the pudental nerve were tested through the bulbocavemosus reflex (BCR) and were found to be abnormal in eight patients, all of whom had abnormal PEPs. Nocturnal penile tumescence (NPT) was found to be normal in 35% of the patients with abnormal PEP and BCR testing. Nocturnal tumescence may therefore be normal in spite of neurogenic erectile dysfunction with normal vasomotor control but defective cerebral modulation of established erections. Disability scores were reviewed and found not to correlate with the presence or absence of impotence.
The presence of plaques in certain areas of the CNS can disrupt specific penile efferent and afferent pathways, resulting in erectile and ejaculatory dysfunction. Paresthesias and decreased sensation in the genital region can result in abnormal perceptions of usually pleasurable sensations or a diminished ability to achieve the erectile state. Brain lesions can result in loss of libido and alterations in orgasmic function.
There are also psychological mechanisms that can result in sexual dysfunction in the MS patient. The effects of severe disability, loss of self-confidence and self-esteem, dependency on others, and changes in the relationships with one's spouse, family, and friends, can drastically influence the ability to achieve a fulfilling sex life. In the presence of significant incoordination, weakness, and diminished visual functioning, it is sometimes difficult to decide whether the etiology of sexual dysfunction is psychological or organic.
Evaluation of the Impotent Male
In our institution, we advocate a multidisciplinary approach to the evaluation and management of the impotent male. We utilize a urologist and psycholo-, gist team to better identify those patients with a significant psychogenic component of their erectile dysfunction. The evaluation by the urologist begins with a precise history of the chief complaint. It is of the utmost importance to categorize the patient's complaint into one of the phases of the male sexual re-sponse-desire, erection, orgasm, or ejaculation.
Diminished desire without an erectile deficit may result from depression, marital discord, or abnormalities of testosterone, prolactin, or estradiol, the male sex hormones. Problems related to premature or retarded ejaculation are almost always of psycho-
The physical examination should identify the presence of Peyronie's disease, hypertension and atherosclerosis, diabetes-related changes, and other endocrine abnormalities (e.g., gynecomastia, thyroid enlargement, atrophic testes). Loss of sensation of the penis can easily be tested with biothesiometry. That instrument is a calibrated vibrator in which the amplitude of the stylus can be reproducibly increased. Diminished penile sensation is a normal consequence of aging (18) . However, severely impaired sensation of the genitals is one of the neurologic deficits seen in both men and women with MS. Although the physiologic function of the penis may be otherwise normal, men lose the positive feedback of direct genital stimulation and secondarily lose their erection.
Men with MS may have other disease states that can contribute to and/or cause their erectile impairment. Penile arterial flow can be measured noninvasively and accurately with a plethysmograph, at rest, after exercise, and after an ischemic episode. This test is performed in all patients at the initial examination.
Visual sexual stimulation, the viewing of a sexually stimulating movie (in a private setting), with an objective measuring device (Rigiscan) in place, may rule out a psychogenic etiology of the patient's erectile dysfunction. If abnormal, NPT with an objective estimate of penile rigidity should be performed (as the man with a slight loss of rigidity because of disease may be converted to 100% loss of erection because of anxiety). The initial psychologic evaluation should include separate, private interviews of the patient and sexual partner (19) . (20, 21) . Karacan, in 1970 , was also the first to suggest that evaluation of nocturnal erections during REM sleep may prove to be a useful tool in the evaluation of impotence. It has been observed that the normal male experiences three to five erections associated with the REM phase of sleep (22, 23) . The documented occurrence of NPT is considered an indication of psychogenic impotence in a male complaining of erectile dysfunction. A number of methods of measuring NPT have been proposed over the years, including silicone mercuryfilled rings, strain gauges, stamps, and snap gauges.
The most thorough NPT evaluation requires a sleep laboratory in which mercury strain gauges are placed at the corona and base of the penis. Other physiological parameters can also be simultaneously monitored via EEG, electrocardiography, and electromyography (EMG) (of the bulbocavernosus). Pictures can also be taken to document the quality of the erections. The patients are also observed for two to three nights to eliminate the &dquo;first night effect&dquo; (24) .
In 1985, Bradley and Timm described the use of the Rigiscan (Dacomed, Minneapolis, MN) , which measures both penile tumescence and rigidity (25) . This portable, battery-powered device has two self-adjusting loops. One loop is placed around the corona, and the other is placed around the base of the penis. The loops intermittently tighten, measuring and recording the penile circumference every 15 s. Firmness is also measured by assessing axial rigidity. The patient monitors himself for three nights and returns the Rigiscan to his urologist. The urologist must then download the stored data into a personal computer for processing and printout (23) . This is an excellent means of screening for psychogenic erectile dysfunction (i.e., confirming the presence of rigid nocturnal erections) when a sleep laboratory is not a feasible option.
Treatment of Erectile Dysfunction
When psychological factors are felt to be the predominant etiology of erectile dysfunction in the MS patient, sexual therapy should be initiated. In creating the treatment plan, psychologists must assess all factors, physiological and psychological, which contribute to the patient's disease. Based on the findings, specific aims of therapy are selected. The patient and his partner are usually treated together and are seen on a regular basis. The five usual goals of psychosexual therapy are (a) establishing mutual responsibility for satisfaction, (b) correcting myths and misinformation, (c) enhancing the degree and amount of physical and psychological stimulation of both partners (especially the one affected by MS, (d) eliminating cognitive interference, and (e) eliminating relationship interference (19) .
When the defect is related to decreased sensation, the couple is advised to use a vibrator and increase the amount of genital stimulation as part of the sex act. For a select group of patients with nonreversible organic erectile dysfunction, intracavernosally injected pharmacological agents are the treatment of choice. Presently, thousands of impotent men are successfully using self-administered intracavernosal injections of vasoactive agents. Papaverine, phentol-amine, and prostaglandin El (PGE,) are the most widely used drugs, which, when injected intracorporally, cause relaxation of arteriolar and cavernosal smooth muscle. Papaverine is a phosphodiesterase inhibitor that causes an increase in cyclic adenosine monophosphate and alters calcium mobilization. The ultimate results of these cellular changes are reduced arteriolar resistance with increased inflow, increased size of the lacunar spaces with an increase in corporal volume, and mechanical venous occlusion (26) .
Phentolamine produces an alpha-adrenergic blockade that acts to reduce sympathetic tone. Phentolamine acts primarily on a-1 postsynaptic receptors. PGE, works by direct intracellular relaxation and is an endogenously occurring compound.
The initiation of intracavernosal injection as a treatment for impotence should follow a specified protocol. Once a patient has been established as being an appropriate candidate for papaverine treatment, he must be counseled on the potential risks and benefits of injection therapy. Patients should also receive a printed summation of the protocol, including a reiteration of possible side-effects, the rules of the program, and what action to take in an emergency. When treatment is initiated, the basic anatomy of the penis should be reviewed with the assistance of the urologist. The patient should then be carefully instructed on the technique of aseptic use of the syringe and its proper disposal. Using normal saline or sterile water, the patient should practice injecting himself with the assistance of his urologist. Once both are comfortable that the patient can correctly inject himself without assistance, he can sign a detailed consent form and initiate treatment. The patient must be reminded to adhere to the specified dosage and frequency of usage and to act expediently to priapism. There appears to be an inverse relationship between the degree of disability in MS and papaverine dose necessary to stimulate an erection (17) . This has been postulated to be secondary to &dquo;autonomic hypersensitivity,&dquo; which has also been seen in spinal cord injury patients. Therefore, lower doses of papaverine should be used in these patients. The motor capabilities of the patient must be taken into consideration when recommending this mode of therapy.
Certain individuals may find limited success with pharmacotherapy for any of a number of reasons (e.g., limited function and incoordination, concurrent vascular disease, etc.) and may wish to consider other therapeutic options. A less invasive but equally cumbersome option is the vacuum suction device (27) .
This new mechanical device (Vrecaid or Corectaid) utilizes a vacuum-to bring blood into the penis, inducing an erection-and a band placed at the base of the penis to restrict venous return. There is also an external device available, which is essentially a firm, fitted condom that simulates an erect penis and is worn by the patient for intercourse. Although these devices limit spontaneity and require some degree of coordinated motor function, they do offer effective nonsurgical alternatives.
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The third option for the MS patient is the placement of the penile prosthetic implant. Over the past two decades, the development of the penile prosthesis proceeded along two distinct lines: the malleable or rigid prosthesis and the inflatable prosthesis (28) . Our experience with penile prosthetic implants has largely been with the inflatable model and several versions of the semirigid prosthesis. A study was conducted in which patients who had undergone the placement of either an inflatable or a semirigid penile prosthesis and their partners were followed and interviewed 1-4 years after their surgery (29) . A major finding of the study was that the surgical implant was responsible for returning a sense of manliness to the impotent male, whether or not coitus was resumed. The choice of prosthetic type-semirigid or inflatable-is one that patient and partner should make. The results of the study revealed a greater degree of difficulty with inflation of the pump than anticipated. The MS patient with a decrease in hand strength or sensation might be a better candidate for the semirigid implant, despite the reduced rate of partner satisfaction. These nuances for achieving a more successful postoperative outcome should be extensively discussed with the patient and sexual partner prior to surgery. Each of the available treatment modalities for erectile dysfunction provides multiple options for MS patients with varying degrees of physical disabilities. The urologist must carefully select the appropriate form of treatment for each case.
Treatment of the Woman with MS and Sexual Dysfunction
The treatment of women with MS who have sexual dysfunction relates directly to change in sensation of the genitalia, weakness of the pelvic musculature, and hyperreflexic bladder contractions during coitus. In those women with decreased perineal sensation, the . treatment is similar to that advocated for men. That is, increase the amount of stimulation with enhanced manual contact and/or with a hand-held vibrator. For those women with pelvic muscle weakness, coital positions must be used that minimize the need for her pelvic thrusting. The woman who has loss of urine during coitus must be instructed to empty her bladder prior to engaging in sexual intercourse.
Bladder Dysfunction and MS
The incidence of neurogenic bladder dysfunction associated with MS has been reported to be as high as 78% (30) . Despite this high incidence, rarely is vesicoureteral dysfunction the sole presenting symptom.
The severity of bladder symptoms has been found to be directly related to the degree of the neurological disability but not to the duration of the disease. The symptoms associated with bladder dysfunction in MS are the most common reasons for hospital admission in these patients. Bladder symptoms may be present even in the mildest cases of MS. It is also uncommon to find secondary urological problems in MS patients; only 15-25% of symptomatic patients will have stones or hydroureteronephrosis on intravenous urography (12) . However, recurrent urinary tract infections (UTI) are very common in patients with MS and are associated with 5% of the deaths in this population.
The symptoms of bladder dysfunction fall into two main categories: irritative and obstructive. Irritative symptoms include urinary frequency, nocturia, urgency, and urge incontinence. Obstructive symptoms include weakened urinary stream, stranguria, intermittency, hesitancy, terminal dribbling, and urinary retention. Miller et al. (30) and Blaivas et al. (31) have shown that on the average 60% of patients with MS have irritative symptoms, 25% have obstructive symptoms, and 15% have a combination of the two. Women tend to have irritative symptoms five times more often than obstructive symptoms, and in men both types occur with equal frequency.
Urodynamic investigation of MS patients usually involves a cystometrogram (CMG), EMG, flow studies, and video voiding cystourethrograms at some institutions (32, 33) . The most common urodynamic finding in MS is detrusor hyperreflexia, which is present in about 60% of all cases (34) . The abnormality of greatest clinical significance is detrusor-sphincter dyssynergia (DSD), which is symptomatic mainly in males. Some studies have shown that more than 50% of MS patients with detrusor hyperreflexia also have DSD. Acontractility of the bladder is uncommon, occurring in 1-40% of MS patients. Some have suggested that the presence of an acontractile bladder makes the diagnosis of MS less likely (35) . The CMG performed at our institution involves the use of a No. 10 French Bard urodynamic catheter that is multilumenal, allowing for measurement of intravesical pressure while filling the bladder with fluid.
The CMG alone can make the diagnosis of detrusor hyperreflexia, impaired detrusor compliance, and detrusor acontractility, but it cannot confirm the diagnosis of DSD. The diagnosis of bladder outlet obstruction can be made based on the high voiding pressures often associated with this entity, but the etiology can only be inferred. Concomitant use of EMG with CMG provides the EMG evidence of persistent sphincteric activity during detrusor contraction consistent with the diagnosis of DSD (36) . EMG can also rule out the presence of DSD, since older males with MS are just as likely to develop bladder outlet obstruction due to prostatic enlargement. Depending on the investigator, when using EMG criteria, DSD has been reported to occur in 30-100% of MS patients.
The presence of DSD is not as important as determining whether there is a clinically significant degree of bladder outlet obstruction. This is further elucidated through the use of pressure flow and free flow studies, assessing detrusor pressure during micturition, video voiding cystourethrograms-which allow visualization of the level of obstruction and bladder neck patency-and a determination of postvoid residual. Also, the voiding cystourethrogram can often demonstrate vesicoureteral reflux, urethral diverticula, bladder diverticula, and the presence of calculi.
Bladder morphology can be visualized and is very useful in confirming the diagnosis of chronic bladder outlet obstruction. The presence of trabeculations, saccules, cellules, and diverticula all support the diagnosis.
Sometimes there can be confusion in making the diagnosis of DSD due to fluctuating detrusor contractions with associated fluctuating sphincteric activity. The differentiation is easily made using voiding pressures, which are rarely elevated, thus alleviating the risk of complications. It is also clear that voiding symptoms do not reliably predict the type of vesical dysfunction, nor do they define the underlying neurologic abnormality. Goldstein et al. have suggested that the presence of bilateral extensor-plantar reflexes may indicate or confirm the presence of detrusor-sphincter dyssynergia and neurogenic bladder outlet obstruction (34) . In their study, they found a positive correlation between the presence of the extensor-plantar reflexes (bilaterally) and DSD in 70% of their cases. Occasionally, the use of bilateral sacral latency testing or sacral evoked potentials can be useful in defining and localizing occult sacral cord lesions. Finally, since neurological findings can change, it is imperative that follow-up urodynamic evaluations be performed (this is especially true in patients with a poor treatment response or a change in symptoms).
Treatment of Bladder Dysfunction
The primary goals of the treatment of bladder dysfunction in the MS patient should be to avoid urinary tract infection, to preserve the upper urinary tract, to establish urinary continence, and to treat secondary urological diseases (e.g., bladder calculi). No treatment should be initiated until the true pathophysiology of the vesicourethral dysfunction has been defined urodynamically. When making decisions about forms of treatment, the physician must also consider the patient's level of disability (i.e., whether the patient is ambulatory, mobile with assistance, or totally disabled) (12) .
In the mobile male patient with MS, the most common problem is DSD, which causes difficult voiding or intermittent urinary retention; these may or may not be accompanied by detrusor hyperreflexia. Detrusor-sphincter dyssynergia can be a serious problem in the male. It can be associated with urinary retention and resultant recurrent UTIs, as well as detrusor noncompliance with high detrusor pressures, which can result in hydroureteronephrosis and impaired renal function. A primary consideration for treatment is intermittent self-catheterization, which is only feasible if the patient has adequate manual dexterity or has someone who can be taught to perform this procedure for the patient. Another alternative treatment in the mobile male who has a demonstrated competent bladder neck is an anteromedial distal sphincterotomy. If the sphincterotomy is performed in the presence of bladder neck incompetence, incontinence will be the end result, requiring condom catheter drainage.
In mobile female patients with MS, the most common bladder problem is detrusor hyperreflexia or instability.. Often, in the absence of DSD, anticholinergic drugs can be used as therapy. In MS patients, lower doses of these agents should be used, since they tend to be quite effective. Probanthine, imipramine, and oxybutinin are the more commonly used agents at our institution. More severe anticholinergic sideeffects tend to be associated with oxybutinin. DSD is much less of a problem in women, although it can cause incomplete emptying of the bladder and resultant UTIs. This tends to occur more commonly in females who are taking anticholinergics for detrusor instability. Therefore, careful follow-up is necessary in all MS patients, male and female.
Treatment of an areflexic bladder in the MS patient is indicated only if complications develop. When the patient presents with a large postvoid residual, ineffective voiding even with straining and cred6, and high intravesical pressures, intermittent straight catheterization is the preferred mode of therapy. If there is infection of the urine, this must also be treated. In females, urethral recalibration or dilatation had been advocated by some urologists, but this procedure can make urinary incontinence worse (37) .
The immobile patient (male and female) has a greater need for better bladder control than does the mobile MS patient. These patients have a greater degree of bladder dysfunction because their neurological status tends to be worse. Many severely disabled MS patients with detrusor hyperreflexia respond to anticholinergics in conjuction with antispasmodics.
All other alternative forms of treatment should be entertained before advancing to an external collecting device. The patients must be kept as dry as possible, since many of them present with open pressure ulcerations and excoriations of the perineum and buttocks.
Continual exposure of these areas to urine and fecal material is the ideal environment for wound infections, UTIs, and sepsis. When an external collecting device is required, this usually means an indwelling urethral catheter in a female and a condom catheter in a male. The indwelling catheter is not a desired alternative, since it is associated with a high incidence of UTIS, upper urinary tract deterioration, and formation of urinary calculi. When this is felt to be the only feasible alternative, a small catheter with a small balloon should be inserted. The presence of a foley catheter can be very irritating to a hyperreflexic detrusor. These patients must be carefully followed, and antibiotic suppression therapy should be considered.
In the immobile male MS patient, the condom catheter drainage will usually suffice unless DSD is present. When DSD is diagnosed, a sphincterotomy should be performed, since preservation of continence is no longer a primary concern (and preservation of the upper urinary tract is the primary goal). When a patient has a catheter, the drainage bag must be kept below the level of the patient at all times, and the tubing must be kept unobstructed.
Some MS patients may have bladder dysfunction, which is refractory to the previously stated forms of therapy. Patients in this category who have some manual dexterity may be considered for some type of urinary diversion procedure. Others may have a very small-capacity, hyperreflexic bladder that could possibly be managed with Helmstein balloon hydro-.. distention, or an augmentation cystoplasty. Mundy et al. (12) described the use of phenol for a chemical cystolysis in which the pelvic plexus supplying the bladder is injected in an attempt to denervate a hyperreflexic detrusor. This procedure was recommended for refractory, immobile MS patients with urgency and uncontrollable leakage around an indwelling foley catheter and for refractory mobile MS patients with uncontrollable urgency and urge incontinence.
Feneley described formal closure of the urethra and placement of an indwelling suprapubic catheter in the immobile patient who voids around his indwelling urethral catheter (37) . A new treatment that remains in the developmental stages in the United States is the bladder neuroprosthesis, which in theory would allow for the electrical stimulation of relatively.normal voiding (after the insertion of small wire electrodes in the sacral micturition centers) (38) .
Conclusions
MS is obviously a progressively debilitating, demyelinating disease of young adults whose sequelae adversely affect areas of functioning essential for &dquo;normal&dquo; socialization. The inability to control one's excretory functions as well as impairment of sexuality and fertility can severely affect one's emotional and social well-being. Due to the global nature of this disease process, physicians must be prepared to counsel patients and provide them with an abundance of current medical therapeutic options and emotional support as necessary.
We have attempted to provide a detailed overview of the epidemiology and pathophysiology of MS, the pathophysiology of bladder and erectile dysfunction in MS, and currently available surgical and nonsurgical treatment options. In spite of the degree of disability that can be caused by MS, many of these patients are able to sustain relatively normal lives (both socially and sexually) with the aid of a compassionate and knowledgeable health care team.
